RecruitingNCT05077124

Safe and Timely Antithrombotic Removal (STAR) Registry

Safe and Timely Antithrombotic Removal (STAR) Registry: International Registry on the Use of CytoSorb for Removal of Antithrombotic Agents in the Acute Hospital Setting

Sponsor

CytoSorbents, Inc

Enrollment

1,000 participants

Start Date

Sep 30, 2021

Study Type

OBSERVATIONAL

Conditions

Blood Loss, Surgical Blood Loss, Postoperative Hemorrhage, Surgical Hemorrhage Postoperative

Summary

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

CytoSorb utilization for antithrombotic removal
Informed consent for prospective registry participation

Exclusion Criteria1

• Use of CytoSorb for purpose other than antithrombotic removal

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECytoSorb

Sorbent hemoperfusion system

Locations(30)

Universitätsklinikum Graz

Graz, Austria

Medizinische Universität Innsbruck

Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee

Klagenfurt, Austria

Medical University of Vienna

Vienna, Austria

Centre Hospitalier Universitaire de Liège

Liège, Belgium, Belgium

OLV ziekenhuis Aalst VZW

Aalst, Belgium

Cliniques Universitaires Saint-Luc

Brussels, Belgium

University Hospital Ghent

Ghent, Belgium

Evangelisches Herzzentrum Coswig

Coswig, Germany

Herzchirurgische Klinik Erlangen

Erlangen, Germany

Universitätsklinikum Essen

Essen, Germany

Asklepios Kliniken Hamburg GmbH

Hamburg, Germany

Medizinische Hochschule Hannover

Hanover, Germany

Universitätsklinikum Heidelberg - Klinik für Herzchirurgie

Heidelberg, Germany

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Herz- und Gefäßchirurgie

Kiel, Germany

Herzzentrum Leipzig and Helios Health Institute GmbH Leipzig

Leipzig, Germany

Artemed Klinikum München Süd GmbH & Co. KG

Munich, Germany

LMU Klinikum Großhadern

Munich, Germany

Deutsches Herzzentrum München

München, Germany

Klinikum Nürnberg

Nuremberg, Germany

Klinikum Oldenburg AöR

Oldenburg, Germany

Krankenhaus der Barmherzigen Brüder Trier

Trier, Germany

Universitätsklinikum Ulm

Ulm, Germany

Skåne University Hospital Lund

Lund, Sweden

Hôpitaux Universitaires Genève

Geneva, Switzerland

Stadtspital Zürich Clinic for Cardiac Surgery

Zurich, Switzerland

Universitätsspital Zürich

Zurich, Switzerland

Blackpool Teaching Hospitals NHS Foundation Trust/ Blackpool Victoria Hospital

Blackpool, United Kingdom

Royal Brompton & Harefield Clinical Group (part of Guy's and St Thomas' NHS Foundation TRUST)

London, United Kingdom

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05077124

Related Trials

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT072178991 location

Tranexamic Acid in Adult Spinal Deformity Surgery

NCT035531861 location

EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER

NCT068220363 locations

Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score

NCT067257321 location

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

NCT017314441 location